×
About 38,014 results

ALLMedicine Acute Coronary Syndrome Center

Research & Reviews  17,069 results

Management of a patient presenting with anterior STEMI with concomitant COVID-19 infect...
https://doi.org/10.1002/ccd.28967
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions REFERENCES; Rothstein ES, Welch TD et. al.

May 29th, 2020 - The coronavirus disease-2019 (COVID-19) is a viral illness with heterogenous clinical manifestations, ranging from mild symptoms to severe acute respiratory distress syndrome and shock caused by the severe acute respiratory syndrome coronavirus-2....

Characteristics of non-culprit plaques in acute coronary syndrome patients with calcifi...
https://doi.org/10.1002/ccd.29005
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions REFERENCES; Kim HO, Kim CJ et. al.

May 28th, 2020 - To investigate the non-culprit plaques (NCPs) characteristics in acute coronary syndrome (ACS) patients with calcified plaques (CP). Recently, a new in vivo classification of calcified culprit plaques in patients with ACS was proposed. Characteris...

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Ne...
https://doi.org/10.1161/CIRCULATIONAHA.120.046786
Circulation Navarese EP, Khan SU et. al.

May 28th, 2020 - Background: New randomized controlled trials (RCTs) have become available on oral P2Y12 inhibitors in acute coronary syndrome (ACS). We aimed to evaluate current evidence comparing the efficacy and safety profile of prasugrel, ticagrelor and clopi...

Supplemental Oxygen Therapy for Nonhypoxemic Patients with Acute Coronary Syndrome.
https://www.ncbi.nlm.nih.gov/pubmed/32463644
American Family Physician; Gibbs LM, Pham K et. al.

May 28th, 2020 - Supplemental Oxygen Therapy for Nonhypoxemic Patients with Acute Coronary Syndrome.|2020|Gibbs LM,Pham K,Langston S,Stigleman S,|

Compliance of Patients with Acute Coronary Syndrome with Treatment Following Their Hosp...
https://doi.org/10.1007/978-3-030-32637-1_12
Advances in Experimental Medicine and Biology; Intas G, Psara A et. al.

May 28th, 2020 - Low compliance rates with medication after an acute coronary syndrome (ACS) is a serious public health problem with adverse socioeconomic implications for both patients and their families as well as for health systems in general. The aims of the s...

see more →

Guidelines  41 results

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193
European Heart Journal; Chieffo A, Stefanini GG et. al.

May 14th, 2020 - The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients an...

ACR Appropriateness Criteria® Chest Pain-Possible Acute Coronary Syndrome.
https://doi.org/10.1016/j.jacr.2020.01.027
Journal of the American College of Radiology : JACR; , Batlle JC et. al.

May 5th, 2020 - Chest pain is a frequent cause for emergency department visits and inpatient evaluation, with particular concern for acute coronary syndrome as an etiology, since cardiovascular disease is the leading cause of death in the United States. Although ...

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Intensive Lipid Lowering in Elderly Patients
https://jamanetwork.com/journals/jamacardiology/article-abstract/2738100
JAMA Cardiology; Gotto,A.

Jul 16th, 2019 - In this issue of JAMA Cardiology, a prespecified post hoc analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) examines the effect of age on higher-intensity lipid lowering in patients after an acute co...

Depression Following Acute Coronary Syndrome Events: Screening and Treatment Guidelines from the AAFP
https://www.aafp.org/afp/2019/0615/od2.html
American Family Physician;

Jun 14th, 2019 - Purpose: To review the evidence and provide clinical recommendations for the screening and treatment of depression in patients who have had a recent acute coronary syndrome event. Methods: This guideline is based on a systematic review of randomi...

see more →

Drugs  243 results see all →

Clinicaltrials.gov  18,779 results

Management of a patient presenting with anterior STEMI with concomitant COVID-19 infect...
https://doi.org/10.1002/ccd.28967
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions REFERENCES; Rothstein ES, Welch TD et. al.

May 29th, 2020 - The coronavirus disease-2019 (COVID-19) is a viral illness with heterogenous clinical manifestations, ranging from mild symptoms to severe acute respiratory distress syndrome and shock caused by the severe acute respiratory syndrome coronavirus-2....

Characteristics of non-culprit plaques in acute coronary syndrome patients with calcifi...
https://doi.org/10.1002/ccd.29005
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions REFERENCES; Kim HO, Kim CJ et. al.

May 28th, 2020 - To investigate the non-culprit plaques (NCPs) characteristics in acute coronary syndrome (ACS) patients with calcified plaques (CP). Recently, a new in vivo classification of calcified culprit plaques in patients with ACS was proposed. Characteris...

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Ne...
https://doi.org/10.1161/CIRCULATIONAHA.120.046786
Circulation Navarese EP, Khan SU et. al.

May 28th, 2020 - Background: New randomized controlled trials (RCTs) have become available on oral P2Y12 inhibitors in acute coronary syndrome (ACS). We aimed to evaluate current evidence comparing the efficacy and safety profile of prasugrel, ticagrelor and clopi...

Supplemental Oxygen Therapy for Nonhypoxemic Patients with Acute Coronary Syndrome.
https://www.ncbi.nlm.nih.gov/pubmed/32463644
American Family Physician; Gibbs LM, Pham K et. al.

May 28th, 2020 - Supplemental Oxygen Therapy for Nonhypoxemic Patients with Acute Coronary Syndrome.|2020|Gibbs LM,Pham K,Langston S,Stigleman S,|

Compliance of Patients with Acute Coronary Syndrome with Treatment Following Their Hosp...
https://doi.org/10.1007/978-3-030-32637-1_12
Advances in Experimental Medicine and Biology; Intas G, Psara A et. al.

May 28th, 2020 - Low compliance rates with medication after an acute coronary syndrome (ACS) is a serious public health problem with adverse socioeconomic implications for both patients and their families as well as for health systems in general. The aims of the s...

see more →

News  1,855 results

Multiple Sclerosis Tied to Increased Risk for Stroke, CVD, Death
https://www.medscape.com/viewarticle/930413

May 11th, 2020 - Multiple sclerosis (MS) is associated with an increased risk for acute coronary syndrome (ACS), stroke, and death, a finding that is unexplained by traditional risk factors, new research suggests. Researchers found that patients with MS had a 28% ...

Prediabetes and Vascular Disease Risk in Newly Diagnosed T2D
https://www.medscape.com/viewarticle/929938

May 4th, 2020 - Takeaway Microvascular and macrovascular diseases were frequently detected at the time of type 2 diabetes (T2D) diagnosis. Individuals with prior prediabetes were at an increased risk of microvascular disease and acute coronary syndrome at the tim...

AUGUSTUS: After ACS or PCI, Aspirin Gives AFib Patients Scant Benefit
https://www.medscape.com/viewarticle/929429

Apr 26th, 2020 - When patients with atrial fibrillation have an acute coronary syndrome event or undergo percutaneous coronary intervention, their window of opportunity for benefiting from a triple antithrombotic regimen was, at best, about 30 days, according to a...

TWILIGHT-COMPLEX: Tap Ticagrelor Monotherapy Early After Complex PCI
https://www.medscape.com/viewarticle/928751

Apr 14th, 2020 - Patients who underwent complex PCI for acute coronary syndrome followed by 3 months of dual-antiplatelet therapy (DAPT) with ticagrelor plus aspirin fared significantly better by dropping aspirin at that point in favor of long-term ticagrelor mono...

Second trial supports ticagrelor alone in ACS after PCI: TICO
https://www.mdedge.com/cardiology/article/219887/acute-coronary-syndromes/second-trial-supports-ticagrelor-alone-acs-after?channel=53
Sue Hughes

Mar 31st, 2020 - A second trial has shown benefit of stopping aspirin 3 months after stenting and continuing solely with ticagrelor monotherapy. The Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI (TICO) study shows very similar results as.

see more →

Patient Education  27 results see all →